| Literature DB >> 21885345 |
M Mörtzell1, G Berlin, T Nilsson, C G Axelsson, M Efvergren, J Audzijoni, A Griskevicius, J Ptak, M Blaha, H Tomsova, G M Liumbruno, P Centoni, E Newman, S Eloot, A Dhondt, J Tomaz, V Witt, G Rock, B Stegmayr.
Abstract
Thrombotic microangiopathy (TMA) is a histopathological feature of various diseases including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). There are many secondary causes of TMA, many of them could mimic TTP or HUS. This article presents a short overview on TMA. In conclusion TMA is the result of various etiology reasons and pathologic reactions with various clinical entities. It is important to focus on a thorough history including family history when deciding on a diagnosis. Analysis of ADAMTS 13 and ADAMTS 13-antibodies may help to decide continued therapy.Entities:
Mesh：
Year: 2011 PMID： 21885345 DOI： 10.1016/j.transci.2011.07.002
Source DB: PubMed Journal: Transfus Apher Sci ISSN： 1473-0502 Impact factor: 1.764